Funding profile · Health tech

Fuse

A Y Combinator Summer 2024 company with four named venture investors and no dollar figure attached to any of it in the public record. No SEC Form D turned up for the entity or its US parent.

4Venture investors named in an early stage round, amount undisclosed
0SEC Form D filings found for Fuse Insight Inc or Fuse Analytics
75%+Voting rights held by the Delaware parent over the UK operating subsidiary

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Jan 2024 Y Combinator, Summer 2024 batch Not disclosed Y Combinator Independent
Undated Early stage VC, marked completed Not disclosed Delight Ventures, Orange Collective, Speedinvest, Transpose Platform Management Data aggregator

What the filings show

No SEC Form D was found for this company under any name variant searched: Fuse Insight Inc, the Delaware parent named in UK filings, Fuse Analytics, the trading name used for the UK subsidiary, or Fuse alone. A broad scan of EDGAR filings that mention the word Fuse turns up more than fifty unrelated entities, including a separate Fuse Analytics, Inc. that filed Form D notices in 2019 and 2020, several venture funds with Fuse in their name, a public shell called Fuse Group Holding, and an unconnected loan origination startup that raised money under the same brand. None of them are this company.

What exists instead is a UK company registration. Fuse Analytics Limited, company number 15639442, was incorporated on April 12, 2024, with a single class of shares and a statement of capital of 1 British pound at incorporation, the standard nominal figure for a UK company that raises its real capital through its US parent rather than at the UK subsidiary level. Company filings do not show a UK share allotment beyond that nominal figure.

Fuse Analytics Limited · persons with significant control filing · notified Apr 12, 2024

Controlling party
Fuse Insight Inc
Governing jurisdiction
Delaware, United States, registered agent address in Dover
Nature of control
Ownership of voting rights, 75 percent or more; right to appoint or remove directors
UK subsidiary
Fuse Analytics Limited, company number 15639442
Filing
UK Companies House, persons with significant control register

Reading the record

  1. The UK filing is a subsidiary shell, not a fundraising record.Fuse Analytics Limited was incorporated with 1 pound of nominal capital. That is normal for a company designed to be owned by a US parent, and it means the UK register will not show how much money the business has actually raised.
  2. The money, if any has closed, sits at the Delaware parent.UK filings name that parent as Fuse Insight Inc, controlling 75 percent or more of the voting rights. No Form D for that name, or for Fuse Analytics under a US CIK, appears in EDGAR. Companies raising only through SAFEs, or under an exemption that does not require a Form D, can look exactly like this: a real capital structure with no federal paper trail yet.
  3. Two data aggregators describe a round that neither dates nor sizes.PitchBook lists an early stage venture round for the company as completed, with four minority investors: Delight Ventures, Orange Collective, Speedinvest, and Transpose Platform Management. It gives no close date and no amount. Delight Ventures independently confirms the relationship by listing Fuse on its own public portfolio page, which is some corroboration that the round happened, but it does not corroborate a size.
  4. The accelerator investment is also undisclosed here.PitchBook separately logs a January 2024 accelerator or incubator deal, consistent with the Y Combinator batch, without a figure. Y Combinator’s standard deal terms have varied by batch and are not confirmed for this company specifically.
  5. The founders are the only people named on the UK side.Sho Sugihara and Oscar Wilsby are the sole two directors of Fuse Analytics Limited, both appointed on the date of incorporation. No outside board observer or investor director is recorded in the UK filings, which is consistent with an early stage company where investor rights sit in the US instruments rather than UK board seats.

Commercial signals

Signal Detail Source type
Team size 3 people at the time of the Y Combinator batch (2024). PitchBook lists 4 employees as of its 2026 profile. Independent
Regulatory or clinical record None. Fuse builds administrative software, not a medical device or diagnostic, and no FDA, NIH, NSF or clinical trial record applies. Not found
Customers Company says it has helped hundreds of providers cut admin time and denials. No customer is named. Company-stated
Compliance Company states it is HIPAA compliant and has achieved SOC 2 Type II compliance via external audit. No audit report or auditor named independently. Company-stated

What to watch

  • A Form D from Fuse Insight Inc, or an amendment that would put a number on the early stage round.
  • A priced Series A announcement, which most Y Combinator companies at this stage eventually make public.
  • UK accounts that stop qualifying for the small company total exemption, which would signal meaningful revenue or headcount growth.
  • Any named customer or auditor that would let the company’s usage and compliance claims be checked against an outside source.

The Fuse story on Healthcare DiscoveryHealthcare Discovery

Related companies

Sources

  1. Public recordFuse Analytics Limited, company overview and filing historyUK Companies House · accessed Sep 25, 2026
  2. Public recordFuse Analytics Limited, persons with significant control registerUK Companies House · accessed Sep 25, 2026
  3. Public recordFuse Analytics Limited, officersUK Companies House · accessed Sep 25, 2026
  4. IndependentFuse (Enterprise Systems) company profile, valuation and investorsPitchBook · Jul 31, 2026
  5. IndependentDelight Ventures portfolio page listing FuseDelight Ventures · accessed May 15, 2026
  6. IndependentFuse company and batch pageY Combinator · accessed Sep 25, 2026
  7. Not foundSEC EDGAR search for Fuse Insight Inc, Fuse Analytics and related name variantsSEC EDGAR · searched Sep 25, 2026
  8. CompanyFuse homepage and about us pagefuseinsight.com · accessed Sep 25, 2026

Compiled from UK Companies House, SEC EDGAR and published data as of September 25, 2026. Healthcare Venture Capital Fund holds no position in Fuse. This page is not an offer to sell or a recommendation to buy any security.